Protocol for evaluating in vivo the activation of the P2RX7 immunomodulator - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Biological Procedures Online Année : 2023

Protocol for evaluating in vivo the activation of the P2RX7 immunomodulator

Résumé

Background: P2RX7 is a purinergic receptor with pleiotropic activities that is activated by high levels of extracellular ATP that are found in inflamed tissues. P2RX7 has immunomodulatory and anti-tumor proprieties and is therefore a therapeutic target for various diseases. Several compounds are developed to either inhibit or enhance its activation. However, studying their effect on P2RX7's activities is limited to in vitro and ex vivo studies that require the use of unphysiological media that could affect its activation. Up to now, the only way to assess the activity of P2RX7 modulators on the receptor in vivo was in an indirect manner. Results: We successfully developed a protocol allowing the detection of P2RX7 activation in vivo in lungs of mice, by taking advantage of its unique macropore formation ability. The protocol is based on intranasal delivery of TO-PRO TM-3, a non-permeant DNA intercalating dye, and fluorescence measurement by flow cytometry. We show that ATP enhances TO-PRO TM-3 fluorescence mainly in lung immune cells of mice in a P2RX7-dependant manner. Conclusions: The described approach has allowed the successful analysis of P2RX7 activity directly in the lungs of WT and transgenic C57BL6 mice. The provided detailed guidelines and recommendations will support the use of this protocol to study the potency of pharmacologic or biologic compounds targeting P2RX7.
Fichier principal
Vignette du fichier
Protocol for evaluating in vivo the activation of the immunomodulator P2RX7.pdf (582.03 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04188434 , version 1 (25-08-2023)

Identifiants

Citer

Serena Janho Dit Hreich, Thierry Juhel, Paul Hofman, Valérie Vouret-Craviari. Protocol for evaluating in vivo the activation of the P2RX7 immunomodulator. Biological Procedures Online, 2023, 25 (1), pp.1. ⟨10.1186/s12575-022-00188-6⟩. ⟨hal-04188434⟩
23 Consultations
24 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More